Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors

Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors

US Patent 10100048 · Granted Oct 16, 2018

Estimated economic value: $452,684,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fused heterocyclic compounds as S1P modulators2020
Fused heterocyclic compounds as S1P modulators2020
Tricyclic quinoline and quinoxaline derivatives2018
Tricyclic quinoline and quinoxaline derivatives2018
Modulators of 5-HT receptors and methods of use thereof2018
Oxindole derivatives carrying an amine-substituted piperidyl-acetidinyl substitu2018
Oxindole derivatives carrying an amine-substituted piperidyl-acetidinyl substitu2018
Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors2018
Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitors2018
Oxindole derivatives carrying a piperidyl-substituted azetidinyl substituent and2017
Oxindole derivatives carrying a piperidyl-substituted azetidinyl substituent and2017
Inhibitor compounds of phosphodiesterase type 10A2017